Drug interactions in English: source-based medicine pair records
How to use this directory
Each record describes a documented medicine pair and links to its source information. Coverage is selective. Missing records do not establish safe use, and these pages do not replace individual review by a qualified healthcare professional.
These records are for information and research. Do not start, stop or change medicines based on a web page. Product formulations, licensed uses and advice can differ by country.
Apalutamide and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Bosentan and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Carbamazepine (Tegretol 200 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Carbamazepine (Tegretol CR 200 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Carbamazepine (Tegretol CR 400 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Ciclosporin (Sandimmun Neoral 100 mg Yumuşak Jelatin Kapsül) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Cipro (Ciprofloxacin) 500 mg (Cipro 500 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Ciprofloxacin (Cipro 250 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Ciprofloxacin (Cipro 750 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Ciprofloxacin (Ciproxin 500 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Clarithromycin (Klacid 500 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Clarithromycin (Klacid MR 500 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Clarithromycin (Klamer 500 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Clarithromycin (Klaromin 500 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Clarithromycin (Macrol 500 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Diflucan 150 mg (Fluconazole) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Dilatrend 25 mg and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Diltiazem hydrochloride (Dilticard SR 90 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Efavirenz and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Enzalutamide and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Fluconazole (Flucoral 150 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Fluconazole (Triflucan 100 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Fluvoxamine (Faverin 100 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Imatinib and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Itraconazole (Itraxyl 100 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Itraconazole (Sporanox 100 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Modafinil (Modiodal 100 mg Tablet) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Paxlovid (Nirmatrelvir/Ritonavir) (Paxlovid 150 mg/100 mg Film Kaplı Tablet) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Phenytoin sodium (Epdantoin 100 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Rifampicin (Rifcap 300 mg Kapsül) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Topiramate (Topamax 25 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Verapamil hydrochloride (İsoptin 80 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Verapamil hydrochloride (İsoptin 120 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.
Verapamil hydrochloride (İsoptin SR 240 mg) and Ubrogepant: interaction and safety
Source-based drug interaction information. Detailed information is available with page access.